Business Description
Compare
Compare
Traded in other countries / regions
109820.Korea IPO Date
2009-11-06Description
Genematrix Inc is a biotech company engaged in the development of the platform and molecular diagnostics products. Its products include NeoPlexTM STI-7 Detection kit, OmniPlex-HPV, PapilloTyper, HepB Typer-Adefovir, and HepB Typer-Precore among others.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.69 | |||||
| Equity-to-Asset | 0.7 | |||||
| Debt-to-Equity | 0.19 | |||||
| Debt-to-EBITDA | -1.36 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 3.4 | |||||
| Beneish M-Score | -2.73 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -15.3 | |||||
| 3-Year Book Growth Rate | -11.5 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 30.76 | |||||
| 9-Day RSI | 34.44 | |||||
| 14-Day RSI | 37.82 | |||||
| 6-1 Month Momentum % | 30.04 | |||||
| 12-1 Month Momentum % | 25.66 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.45 | |||||
| Quick Ratio | 3.81 | |||||
| Cash Ratio | 3.24 | |||||
| Days Inventory | 212.69 | |||||
| Days Sales Outstanding | 61.09 | |||||
| Days Payable | 42.06 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -0.17 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 54.96 | |||||
| Operating Margin % | -16.88 | |||||
| Net Margin % | -34.12 | |||||
| FCF Margin % | -17.76 | |||||
| ROE % | -16.25 | |||||
| ROA % | -11.64 | |||||
| ROIC % | -11.66 | |||||
| ROC (Joel Greenblatt) % | -33.58 | |||||
| ROCE % | -13.19 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 5.29 | |||||
| PB Ratio | 2.72 | |||||
| Price-to-Tangible-Book | 2.73 | |||||
| EV-to-EBIT | -13.12 | |||||
| EV-to-EBITDA | -15.97 | |||||
| EV-to-Revenue | 4.27 | |||||
| EV-to-FCF | -24.04 | |||||
| Price-to-Projected-FCF | 4.18 | |||||
| Price-to-Median-PS-Value | 0.6 | |||||
| Price-to-Net-Current-Asset-Value | 5.1 | |||||
| Price-to-Net-Cash | 10 | |||||
| Earnings Yield (Greenblatt) % | -7.62 | |||||
| FCF Yield % | -3.38 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Genematrix Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 10,250.892 | ||
| EPS (TTM) (â‚©) | -175 | ||
| Beta | 1.22 | ||
| Volatility % | 61.25 | ||
| 14-Day RSI | 37.82 | ||
| 14-Day ATR (â‚©) | 191.073554 | ||
| 20-Day SMA (â‚©) | 2916.5 | ||
| 12-1 Month Momentum % | 25.66 | ||
| 52-Week Range (â‚©) | 2270 - 7180 | ||
| Shares Outstanding (Mil) | 19.96 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Genematrix Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Genematrix Inc Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Genematrix Inc Frequently Asked Questions
What is Genematrix Inc(XKRX:109820)'s stock price today?
The current price of XKRX:109820 is â‚©2695.00. The 52 week high of XKRX:109820 is â‚©7180.00 and 52 week low is â‚©2270.00.
When is next earnings date of Genematrix Inc(XKRX:109820)?
The next earnings date of Genematrix Inc(XKRX:109820) is .
Does Genematrix Inc(XKRX:109820) pay dividends? If so, how much?
Genematrix Inc(XKRX:109820) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers